Azucena Ramos-Morales, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 223 | 0.790 |
Why?
|
| Burkitt Lymphoma | 1 | 2023 | 333 | 0.760 |
Why?
|
| Fusobacterium nucleatum | 1 | 2017 | 165 | 0.530 |
Why?
|
| Leukemia | 1 | 2023 | 1511 | 0.500 |
Why?
|
| Leukemia, Lymphoid | 1 | 2023 | 309 | 0.210 |
Why?
|
| Stem Cells | 1 | 2012 | 3525 | 0.160 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 3810 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6853 | 0.150 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2023 | 1442 | 0.140 |
Why?
|
| Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 10 | 0.140 |
Why?
|
| Proto-Oncogenes | 1 | 2017 | 320 | 0.130 |
Why?
|
| Mutagenesis | 1 | 2019 | 1233 | 0.120 |
Why?
|
| Citric Acid Cycle | 1 | 2016 | 230 | 0.120 |
Why?
|
| Creatine Kinase | 1 | 2017 | 691 | 0.120 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 352 | 0.120 |
Why?
|
| Quinolines | 1 | 2019 | 758 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2535 | 0.110 |
Why?
|
| Cisplatin | 1 | 2019 | 1642 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2020 | 817 | 0.110 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 645 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 1173 | 0.100 |
Why?
|
| Clone Cells | 1 | 2014 | 1663 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 996 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2017 | 3605 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2020 | 3390 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2023 | 10181 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2012 | 23362 | 0.080 |
Why?
|
| Mice | 6 | 2023 | 81138 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2014 | 2524 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2014 | 2063 | 0.060 |
Why?
|
| Animals | 7 | 2023 | 167838 | 0.060 |
Why?
|
| Haploidy | 1 | 2023 | 133 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1619 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 1709 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2012 | 1698 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2867 | 0.050 |
Why?
|
| Neoplasms | 2 | 2022 | 22019 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2020 | 10440 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8491 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9590 | 0.040 |
Why?
|
| Cell Survival | 2 | 2020 | 5796 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2017 | 12106 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2019 | 243 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 1771 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2020 | 496 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13621 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2020 | 580 | 0.030 |
Why?
|
| U937 Cells | 1 | 2016 | 262 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2019 | 491 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2020 | 1532 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2016 | 362 | 0.030 |
Why?
|
| Skull | 1 | 2020 | 815 | 0.030 |
Why?
|
| Humans | 8 | 2023 | 759255 | 0.030 |
Why?
|
| DNA Repair | 1 | 2023 | 2039 | 0.030 |
Why?
|
| Myelopoiesis | 1 | 2014 | 134 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1886 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 3605 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2015 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 788 | 0.030 |
Why?
|
| Transfection | 1 | 2019 | 5783 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3584 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 752 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2014 | 1090 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2017 | 5039 | 0.020 |
Why?
|
| DNA Damage | 1 | 2019 | 2442 | 0.020 |
Why?
|
| Oxygen | 1 | 2020 | 4188 | 0.020 |
Why?
|
| Proteins | 1 | 2023 | 6029 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2014 | 2608 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5209 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 3443 | 0.020 |
Why?
|
| Metabolomics | 1 | 2017 | 1620 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9528 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5870 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 3600 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2017 | 6195 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 16871 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9374 | 0.010 |
Why?
|
| Female | 4 | 2020 | 390240 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12580 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5630 | 0.010 |
Why?
|
| Male | 3 | 2020 | 358719 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 40109 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 58867 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 168617 | 0.000 |
Why?
|
| Middle Aged | 1 | 2017 | 219653 | 0.000 |
Why?
|
| Adult | 1 | 2017 | 219390 | 0.000 |
Why?
|